The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of sintilimab in combination with SBRT and LDRT in PD-L1 positive treatment naïve-stage IV non-small cell lung cancer: A phase I study (IHC study).
 
Jianxin Xue
No Relationships to Disclose
 
Xiaojuan Zhou
No Relationships to Disclose
 
Laiyan Zhou
No Relationships to Disclose
 
Meijuan Huang
No Relationships to Disclose
 
Youling Gong
No Relationships to Disclose
 
Bingwen Zou
No Relationships to Disclose
 
Jiang Zhu
No Relationships to Disclose
 
Yongmei Liu
No Relationships to Disclose
 
Feng Peng
No Relationships to Disclose
 
Yan Zhang
No Relationships to Disclose
 
Min Yu
No Relationships to Disclose
 
Yanying Li
No Relationships to Disclose
 
Feifei Na
No Relationships to Disclose
 
Weigang Xiu
No Relationships to Disclose
 
Xuanwei Zhang
No Relationships to Disclose
 
Lin Zhou
No Relationships to Disclose
 
Yong Xu
No Relationships to Disclose
 
Jin Wang
No Relationships to Disclose
 
You Lu
Honoraria - AstraZeneca; BeiGene; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; BeiGene; Bristol-Myers Squibb; Merck Sharp & Dohme; Pfizer; Roche/Genentech